Emergent Health Corp (OTCPK:EMGE) executed a Letter of Intent to acquire Pressure BioSciences, Inc. (OTCPK:PBIO) on July 6, 2022. On July 19, 2022, Regen's Bankruptcy Motion to Dismiss was approved by the US Bankruptcy Court in New Jersey. The transaction is anticipated to close from mid-to-end July 2022. The transaction is expected to close on or about August 1, 2022.
Emergent Health Corp (OTCPK:EMGE) completed the acquisition of Pressure BioSciences, Inc. (OTCPK:PBIO) on August 2, 2022. As per the terms of the transaction, acquisition was made for preferred stock of Emergent and other financial considerations. Jim Morrison, President and Chief Executive Officer of Regen has joined the Emergent Board of Directors.